VIR 外匯新聞
Vir Biotechnology Appoints Mark Eisner As EVP And Chief Medical Officer
Immunology company Vir Biotechnology, Inc. (VIR) announced Wednesday that Mark Eisner will join the company as Executive Vice President and Chief Medical Officer (CMO), effective June 03, 2024.
RTTNews
|
171天前
